StephenJHallidayMDMSCI
Pulmonology • Madison, WICritical Care Medicine, Interstitial Lung Diseases
Assistant Professor of Medicine
Dr. Halliday is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
600 Highland Ave
Madison, WI 53792Phone+1 608-263-7203
Summary
- I am a pulmonary and critical care physician with an interest in interstitial lung disease, critical care, bronchoscopy and other pulmonary procedures, and medical education. I completed my residency, chief residency, and fellowship at Vanderbilt, and now practice at University of Wisconsin Hospitals and Clinics, and the William S. Middleton VA Hospital.
Education & Training
Vanderbilt UniversityMSCI, 2017 - 2019
Vanderbilt University Medical CenterFellowship, Pulmonary Disease and Critical Care Medicine, 2015 - 2019- Vanderbilt University Medical CenterChief Residency, Internal Medicine, 2014 - 2015
- Vanderbilt University Medical CenterResidency, Internal Medicine, 2011 - 2014
The University of Texas Health Science Center at San AntonioClass of 2011, M.D.- Davidson CollegeBS, Biology, 2003 - 2007
Certifications & Licensure
IL State Medical License 2019 - 2026
WI State Medical License 2019 - 2025
TN State Medical License 2013 - 2021- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- Distinction in Leadership Training Vanderbilt University Medical Center, 2015
- Inductee Alpha Omega Alpha Honor Medical Society, 2011
Clinical Trials
- A Clinical Study to Test How Effective and Safe GLPG1690 is for Participants With Idiopathic Pulmonary Fibrosis (IPF) When Used Together With Standard of Care Start of enrollment: 2018 Nov 05
- A Study to Evaluate the Efficacy and Safety of Recombinant Human Pentraxin-2 (rhPTX-2; PRM-151) in Participants With Idiopathic Pulmonary Fibrosis Start of enrollment: 2021 Mar 19
- Zephyrus II: Efficacy and Safety Study of Pamrevlumab in Participants With Idiopathic Pulmonary Fibrosis (IPF) Start of enrollment: 2020 Sep 30
- Join now to see all
Publications & Presentations
PubMed
- 52 citationsA Multicenter Randomized Trial of a Checklist for Endotracheal Intubation of Critically Ill AdultsDavid R. Janz, Matthew W. Semler, Aaron M. Joffe, Jonathan D Casey, Robert J. Lentz
Chest. 2017-09-14 - 66 citationsHuman PAH is characterized by a pattern of lipid-related insulin resistanceAnna R. Hemnes, J. Matthew Luther, Christopher J. Rhodes, Jason P. Burgess, James Carlson
JCI Insight. 2019-01-10 - 37 citationsSix-minute walk distance in healthy young adults.Stephen J. Halliday, Li Wang, Chang Yu, Brian P. Vickers, John H. Newman
Respiratory Medicine. 2020-03-19
Press Mentions
Researchers at Vanderbilt Publish First Study from PHA’s 2018 Research RoomNovember 29th, 2018
Grant Support
- Clinical and Translational Research Training Program in Pulmonary MedicineNIH2017–2019
Professional Memberships
- Member
- Member
- Pulmonary Hypertension AssociationMember
- Member
External Links
- UW Sitehttps://www.uwhealth.org/findadoctor/profile/stephen-j-halliday-md/11168
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
